Cargando…

Hepatitis B sero-prevalence among hematology patients: importance of Anti-HbcAb and efficiency of antiviral prophylaxis

OBJECTIVES: Hepatitis B infection is an important problem in immune suppressed patients. Anti HbcAb is an important marker that shows past exposure to virus. In this study, we retrospectively searched HBV serology among the patients who had Bone Marrow Transplantation (BMT) or chemotherapies (CT) at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kantar, Funda Ugur, Kahraman, Selda, Ece, Gulfem, Cagırgan, Seckin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Makerere Medical School 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993312/ https://www.ncbi.nlm.nih.gov/pubmed/36910386 http://dx.doi.org/10.4314/ahs.v22i3.60

Ejemplares similares

HBsAb and HBcAb Have No Significant Effect on the Progression of SLE and RA
por: WANG, Fen, et al.
Publicado: (2017)

Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma
por: Masarone, Mario, et al.
Publicado: (2014)

HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma
por: Wang, Wen‐Qiang, et al.
Publicado: (2023)

Moderate Risk of Hepatitis B Virus Reactivation in HBsAg(−)/HBcAb(+) Carriers Receiving Rituximab for Rheumatoid Arthritis
por: Kuo, Meng Hsuan, et al.
Publicado: (2020)

Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis
por: Morisco, Filomena, et al.
Publicado: (2014)

Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia
por: Toscanini, Federica, et al.
Publicado: (2011)

HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy
por: Malagnino, Vincenzo, et al.
Publicado: (2019)

Baseline quantitative HBcAb strongly predicts undetectable HBV DNA and RNA in chronic hepatitis B patients treated with entecavir for 10 years
por: Zhang, Xi, et al.
Publicado: (2021)

Prevalence of Cirrhosis/Advanced Fibrosis Among HBsAg-Negative and HBcAb-Positive US Adults: A Nationwide Population-Based Study
por: Huang, Shuai-Wen, et al.
Publicado: (2022)

Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy
por: Lin, Ying-Cheng, et al.
Publicado: (2021)

Risk of hepatitis B reactivation in HBsAg−/HBcAb+ patients after biologic or JAK inhibitor therapy for rheumatoid arthritis: A meta‐analysis
por: Hong, Xuezhi, et al.
Publicado: (2023)

HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients
por: Malagnino, Vincenzo, et al.
Publicado: (2020)

Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21
por: Giordano, Claudia, et al.
Publicado: (2023)

Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers
por: Malagnino, Vincenzo, et al.
Publicado: (2021)

Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study
por: Tien, Ya-Chih, et al.
Publicado: (2018)

The Sero-Prophylaxis of Measles
por: Benson, W. T., et al.
Publicado: (1927)

HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort
por: Malagnino, Vincenzo, et al.
Publicado: (2021)

Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort
por: Malagnino, Vincenzo, et al.
Publicado: (2023)

Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4)
por: Boğa, Can, et al.
Publicado: (2015)

Prevalence of HBc-Ab among HBs-Ag negative healthy blood donors in south of Iran
por: Khorami, Farhad, et al.
Publicado: (2013)

Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage
por: Gedik, Habip, et al.
Publicado: (2014)

Beam position for the 2m HBC
por: Perreau, J M, et al.
Publicado: (1964)

Report on the future program for the HBC 200
por: CERN. Geneva. Track Chamber Committee
Publicado: (1975)

Memorandum : HBC 200 Camera Window
por: Stierlin, R G, et al.
Publicado: (1975)

Geometry titles for the 2m HBC
por: Kellner, G
Publicado: (1969)

Isolated Anti-HBc: Significance and Management
por: MORETTO, Florian, et al.
Publicado: (2020)

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
por: Buti, María, et al.
Publicado: (2017)

Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
por: Buti, María, et al.
Publicado: (2018)

Antiviral Immunity and Prophylaxis
Publicado: (2011)

Occult hepatitis B: Evolving challenges and new perspectives
por: Akarsu, Mesut, et al.
Publicado: (2011)

Test on double pulsing of the 2m HBC
por: Blumenfeld, H, et al.
Publicado: (1970)

Proposals of experiments to be performed with stopping $K^{-}$ in HBC
por: Padua Bubble Chamber and Separator Group, et al.
Publicado: (1962)

Optical constant determination for the 2 meter HBC
por: Bergé, J P
Publicado: (1975)

Production of the HBc Protein from Different HBV Genotypes in E. coli. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA
por: Petrovskis, Ivars, et al.
Publicado: (2021)

Automatic Measurement of Six Fiducials on HBC 200 Film
por: Hooper, J E
Publicado: (1972)

Provisional schedule for 2-metre H.B.C.
por: CERN. Geneva. Track Chamber Committee
Publicado: (1966)

Proposal for an experiment on $K^{+}$ Stopping in the 80 cm HBC
por: CERN. Geneva.Track Chamber Committee
Publicado: (1962)

Proposal for CERN 2-METRE H.B.C.
por: CERN. Geneva. Track Chamber Committee
Publicado: (1965)

Distribution of Yeast-Like Fungi at a University Hospital in Turkey
por: Ece, Gulfem
Publicado: (2014)

The Sero-Diagnosis of Syphilis
por: Sutherland, W. D.
Publicado: (1913)

Cannot write session to /tmp/vufind_sessions/sess_n0ied7e9elca0d18eea3m1kml1